a radioimmunotherapy regimen that uses Rituxan, indium-111 Zevalin, and yttrium-90 Zevalin to target and attack cancerous B-cells in the blood.

GoldBamboo

... IBRITUMOMAB TIUXETAN (Zevalin®) is a protein that targets specific lymphoma cells. To be effective ibritumomab tiuxetan is linked to a radioactive agent called yttrium chloride (Y-90). The medicine allows radiation to be delivered directly to the sites of the lymphoma. Generic ibritumomab tiuxetan injections are not available. ...
Drug Digest - more...

Ibritumomab tiuxetan, also sold under the trade name ZevalinĀ®, is a monoclo ...
Wikipedia - [full article]

Resources